Tin tức & Cập nhật

RSV may worsen clinical outcomes in HF patients

01 Nov 2024 bởi

A retrospective analysis presented at HSFA ASM 2024 shows that respiratory syncytial virus (RSV) infection in individuals with heart failure (HF) is associated with greater adverse clinical outcomes.

RSV may worsen clinical outcomes in HF patients

01 Nov 2024

Maintenance lisdexamfetamine shows promise in binge-eating disorder treatment

01 Nov 2024

Adults with binge-eating disorder and obesity who responded to acute lisdexamfetamine (LDX) treatment demonstrate sustained benefits during the subsequent 12-week maintenance phase, with better eating-disorder psychopathology outcomes and greater weight-loss relative to placebo, as shown in a study.

Maintenance lisdexamfetamine shows promise in binge-eating disorder treatment

01 Nov 2024

Thumbs up for HeartMate 3 in cohorts with high perioperative risk

31 Oct 2024 bởi

The HeartMate 3 left ventricular assist device (LVAD) can offer a lifeline to patients with severe heart failure, including those with morbid obesity and advanced chronic kidney disease (CKD), medical conditions that carry increased perioperative risks, as suggested in a retrospective cohort study.

Thumbs up for HeartMate 3 in cohorts with high perioperative risk

31 Oct 2024

Sacubitril/valsartan maintains efficacy, safety in HF patients with hypotension

31 Oct 2024

Both symptomatic and asymptomatic hypotension are associated with worse outcomes during treatment with either enalapril or sacubitril/valsartan, but the benefits derived from the combination therapy are maintained or even improved in heart failure (HF) patients with hypotension, a study has shown.

Sacubitril/valsartan maintains efficacy, safety in HF patients with hypotension

31 Oct 2024

Early maternal care boosts mental health in kids

31 Oct 2024 bởi

Children who received quality care from mothers during their formative years show better mental health functioning despite later clinical diagnosis, reports a Singapore study. This suggests that early maternal care promotes an overall long-term protective effect.

Early maternal care boosts mental health in kids

31 Oct 2024

Tumour size, age predict survival in dermatofibrosarcoma protuberans

31 Oct 2024

The incidence of dermatofibrosarcoma protuberans (DFSP) is two times higher among Black than White individuals, reports a study.

Tumour size, age predict survival in dermatofibrosarcoma protuberans

31 Oct 2024

Lacosamide safe, efficacious for long-term seizure control in idiopathic generalized epilepsy

31 Oct 2024

In patients with idiopathic generalized epilepsy, adjunctive lacosamide treatment in the long term may safely reduce the frequency of generalized onset tonic–clonic seizures (GTCS), as shown in the open-label extension EP0012 trial.

Lacosamide safe, efficacious for long-term seizure control in idiopathic generalized epilepsy

31 Oct 2024

Acoramidis boosts clinical outcomes in ATTR-CM

31 Oct 2024 bởi

Treatment with the investigational agent acoramidis significantly reduced all-cause mortality (ACM) and recurrent cardiovascular-related hospitalizations (CVH) at 30 months for patients with transthyretin amyloid cardiomyopathy (ATTR-CM), according to a post hoc analysis of the phase III ATTRibute-CM trial presented at HFSA 2024.

Acoramidis boosts clinical outcomes in ATTR-CM

31 Oct 2024

Cardiac biomarker profile in ATTR-CM looks good with vutrisiran

30 Oct 2024 bởi

In the treatment of patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), the use of the small interfering ribonucleic acid (siRNA) vutrisiran helps reduce and maintain the stability of NT-proBNP and troponin I—biomarkers associated with increased mortality in this population, as reported in a late-breaking clinical research presentation in HFSA 2024.

Cardiac biomarker profile in ATTR-CM looks good with vutrisiran

30 Oct 2024

Mavacamten mends cardiac biomarkers in patients with HFpEF

30 Oct 2024 bởi

Treatment with mavacamten results in improvements in cardiac biomarkers of wall stress and injury, as shown by reduced NT-proBNP and troponin, without sustained left ventricular ejection fraction (LVEF) reductions, according to the preliminary findings of the EMBARK-HFpEF trial.

Mavacamten mends cardiac biomarkers in patients with HFpEF

30 Oct 2024

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

RSV may worsen clinical outcomes in HF patients

RSV may worsen clinical outcomes in HF patients

Maintenance lisdexamfetamine shows promise in binge-eating disorder treatment

Maintenance lisdexamfetamine shows promise in binge-eating disorder treatment

Thumbs up for HeartMate 3 in cohorts with high perioperative risk

Thumbs up for HeartMate 3 in cohorts with high perioperative risk

Sacubitril/valsartan maintains efficacy, safety in HF patients with hypotension

Sacubitril/valsartan maintains efficacy, safety in HF patients with hypotension

Early maternal care boosts mental health in kids

Early maternal care boosts mental health in kids

Tumour size, age predict survival in dermatofibrosarcoma protuberans

Tumour size, age predict survival in dermatofibrosarcoma protuberans

Lacosamide safe, efficacious for long-term seizure control in idiopathic generalized epilepsy

Lacosamide safe, efficacious for long-term seizure control in idiopathic generalized epilepsy

Acoramidis boosts clinical outcomes in ATTR-CM

Acoramidis boosts clinical outcomes in ATTR-CM

Cardiac biomarker profile in ATTR-CM looks good with vutrisiran

Cardiac biomarker profile in ATTR-CM looks good with vutrisiran

Mavacamten mends cardiac biomarkers in patients with HFpEF

Mavacamten mends cardiac biomarkers in patients with HFpEF